News
GLP-1 medications work by mimicking a hormone that regulates blood sugar, suppresses appetite and slows digestion, which in turn is said to 'reduce food noise,' particularly for those who struggle ...
Experts have issued a cautionary note that around half a million people using weight loss injections could potentially invalidate their travel insurance this summer. Medications such as Mounjaro and ...
Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as January.
A MOUNJARO user has revealed the four foods she has to avoid whilst using fat jabs. Savvy mum Vic has been on Mounjaro for ...
WEIGHT loss jabs could boost men’s sex lives, a study suggests. Research found injections like Wegovy and Mounjaro can raise ...
Experts are warning people using weight-loss jabs could be invalidating travel insurance if they fail to declare the ...
Research indicates GLP-1 receptor agonists, like Ozempic, may elevate testosterone levels in men while promoting weight loss.
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...
Wegovy, a weight loss drug, is gaining popularity for its effectiveness, but experts emphasize that it's most successful when ...
WW International relists on Nasdaq, pivoting to menopause care with GLP-1 drugs and coaching. Click here to read an analysis ...
The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the ...
Investing.com -- Hims & Hers CEO Andrew Dudum has shared new information about the company’s terminated partnership with Novo Nordisk (NYSE: NVO ), which ended in June 2025, in an interview with The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results